Skip to content

A prospective clinical study on meditation in patients with chronic schizophrenia

A prospective clinical study on meditation in patients with chronic schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014913
Enrollment
Unknown
Registered
2018-02-19
Start date
2018-02-22
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Meditation training group:Meditation training
control group:General rehabilitation programs

Sponsors

The first Minzheng Mental Health Center, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. According to DSM-IV diagnostic criteria for schizophrenia; 2. Aged >= 18 years; 3. Disease course more than 5 years; 4. Experiencing residual symptoms of hallucination and/or delusions (subscale P3 score on the PANSS >= 5, and/or out of the subscale items P1, P5, P6, G1, G3 and G9, scores for at least two of them >= 5); 5. Stable condition; 6. MMSE >= 24; 7. The patients were approved by the hospital ethics committee and the patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Major Axis I disorder; 2. Obviously impaired cognitive function; 3. Speech and communication disorder; 4. Severe physical diseases; 5. Substance abuse/dependence.

Design outcomes

Primary

MeasureTime frame
CD5L level and its change;Reduction rate of PANSS score;

Secondary

MeasureTime frame
The Short Form-36 Health Survey;Five Facet Mindfulness Questionnaire;EEG measurement;MRI measurement;PANSS score;

Countries

China

Contacts

Public ContactJialing Sheng

The first Minzheng Mental Health Center, Shanghai, China

shengjl@126.com+86 18916078789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026